EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Biochemical and antidiabetic properties of Elaeocarpus angustifolius Blume: In vitro, In vivo, and In silico insights

Sabina Panth iD, Rojina Devkota, Amar Waiba iD, Tika Ram Lamichhane, Prajwal Acharya, Begum Rokeya, Amit Jaisi, Achyut Adhikari iD

PLOS One · 08.06.2026 · 21 (6) · e0349796

DOI: 10.1371/journal.pone.0349796 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, online erschienen am 08.06.2026. Verfasst von Sabina Panth und 7 weiteren Autor:innen. Beteiligte Einrichtung: Central Department of Chemistry, Tribhuvan University, Kathmandu, Nepal. Hauptthemen laut MEDLINE: Hypoglycemic Agents, Plant Extracts, Elaeocarpaceae. Die Arbeit nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetes poses an utmost threat to human health; significant progress in the discovery of antidiabetic drugs has been made, but their side effects cannot be ignored. As a plant-based alternative, this study explored the pharmacological potential of Elaeocarpus angustifolius Blume (Rudraksha), emphasizing its antioxidant and antidiabetic activities, supported by in silico analysis. Phytochemical screening of the methanol bark extract confirmed the presence of flavonoids, alkaloids, carbohydrates, glycosides, terpenoids, tannins, and phenols. The extract exhibited high total phenolic and flavonoid contents (182.73 ± 0.001 mg GAE/g and 48.78 ± 0.06 mg QE/g, respectively). The LC–MS analysis of the ethyl acetate fraction identified thirteen phytoconstituents, including phenolic acids, flavonoids, and tannins. The ethyl acetate fraction demonstrated significant antioxidant activity (IC₅₀ = 1.47 ± 0.37 µg/mL), outperforming quercetin (IC₅₀ = 4.87 ± 0.16 µg/mL). Enzyme inhibition assays revealed methanol extract has strong α-glucosidase (IC₅₀ = 0.79 ± 0.13 µg/mL) and α-amylase (IC₅₀ = 3.48 ± 0.00 µg/mL) inhibitory effects, comparable to acarbose (IC₅₀ = 13.51 ± 0.22 µg/mL and IC₅₀ = 25.30 ± 0.85 µg/mL), respectively. In a 28-day in vivo study, oral administration of the methanol bark extract significantly (p < 0.01) reduced fasting serum glucose levels and improved lipid profiles, with decreases in triglycerides (5%) and total cholesterol (2%), and an increase in HDL (5%) compared with baseline. The extract-treated group also showed higher hepatic glycogen content (14.06 ± 0.002 mg/mL) than the Gliclazide-treated group (12.82 ± 0.002 mg/mL). In silico molecular docking identified Corilagin exhibiting the highest binding affinity (−10.3 kcal/mol), stable interaction (RMSD = 1.469 ± 0.133 Å), and favorable binding free energy (ΔG BFE = −27.48 ± 3.15) with α-amylase, suggesting that it may act as a competitive inhibitor of an enzyme’s active site. Overall, these findings highlight that E. angustifolius bark significantly inhibits glucose absorption and improves dyslipidemia to some extent, while in silico analysis suggests that Corilagin has potential as an inhibitory activity against type-2 diabetes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hypoglycemic AgentsPlant ExtractsElaeocarpaceaeAnimalsAntioxidantsalpha-AmylasesPlant Barkalpha-GlucosidasesGlycoside Hydrolase InhibitorsComputer SimulationMolecular Docking SimulationBlood Glucose

Substanzen

Hypoglycemic AgentsPlant ExtractsAntioxidantsalpha-Amylasesalpha-GlucosidasesGlycoside Hydrolase InhibitorsBlood Glucose

Autor:innen und Institutionen

  • Central Department of Chemistry, Tribhuvan University, Kathmandu, Nepal.
  • Central Department of Physics, Tribhuvan University, Kathmandu, Nepal.
  • Department of Pharmacology, Bangladesh University of Health Sciences, Dhaka, Bangladesh.
  • Department of Chemistry, Faculty of Science, Chulalongkorn University, Bangkok, Thailand.

ORCID-Profile: Sabina Panth, Amar Waiba, Achyut Adhikari

Zitieren

APA

Panth, S., Devkota, R., Waiba, A., Lamichhane, T. R., Acharya, P., Rokeya, B., Jaisi, A., & Adhikari, A. (2026). Biochemical and antidiabetic properties of Elaeocarpus angustifolius Blume: In vitro, In vivo, and In silico insights. PLOS One, 21(6), e0349796. https://doi.org/10.1371/journal.pone.0349796

Vancouver

Panth S, Devkota R, Waiba A, Lamichhane TR, Acharya P, Rokeya B, et al. Biochemical and antidiabetic properties of Elaeocarpus angustifolius Blume: In vitro, In vivo, and In silico insights. PLOS One. 2026;21(6):e0349796. doi:10.1371/journal.pone.0349796

BibTeX
@article{Panth2026,
  author = {Panth, Sabina and Devkota, Rojina and Waiba, Amar and Lamichhane, Tika Ram and Acharya, Prajwal and Rokeya, Begum and Jaisi, Amit and Adhikari, Achyut},
  title = {Biochemical and antidiabetic properties of Elaeocarpus angustifolius Blume: In vitro, In vivo, and In silico insights},
  journal = {PLOS One},
  year = {2026},
  volume = {21},
  number = {6},
  pages = {e0349796},
  doi = {10.1371/journal.pone.0349796}
}
Kostenlos starten →